Achilles Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Achilles Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Achilles Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Achilles Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $39k | 34k | 1.14 |
| 2024-09-30 | $17k | 16k | 1.02 |
| 2024-06-30 | $7.3k | 8.9k | 0.82 |
| 2024-03-31 | $23k | 18k | 1.25 |
| 2023-12-31 | $18 | 20 | 0.90 |
| 2023-09-30 | $46k | 50k | 0.91 |
| 2023-06-30 | $69k | 73k | 0.95 |
| 2022-06-30 | $0 | 6.3k | 0.00 |
| 2022-03-31 | $0 | 6.2k | 0.00 |
Top funds holding Achilles Therapeutics
View all funds holding Achilles Therapeutics